Page last updated: 2024-10-15

chloroacetaldehyde and Encephalopathy, Toxic

chloroacetaldehyde has been researched along with Encephalopathy, Toxic in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Ifosfamide is an alkylating agent with well-demonstrated efficacy against a large number of malignant diseases."2.42Neurological toxicity of ifosfamide. ( Giometto, B; Nicolao, P, 2003)
" With cyclophosphamide it shares a toxicity profile characterized by myelosuppression and urotoxicity, but ifosfamide has additionally disclosed adverse neurological effects."2.42Neurological toxicity of ifosfamide. ( Giometto, B; Nicolao, P, 2003)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, L1
Xiong, X1
Hou, X1
Wei, H1
Zhai, J1
Xia, T1
Gong, X1
Gao, S1
Feng, G1
Tao, X1
Zhang, F1
Chen, W1
Nicolao, P1
Giometto, B1

Reviews

1 review available for chloroacetaldehyde and Encephalopathy, Toxic

ArticleYear
Neurological toxicity of ifosfamide.
    Oncology, 2003, Volume: 65 Suppl 2

    Topics: Acetaldehyde; Animals; Antineoplastic Agents, Alkylating; Brain; Carbocysteine; Central Nervous Syst

2003

Other Studies

1 other study available for chloroacetaldehyde and Encephalopathy, Toxic

ArticleYear
Wuzhi capsule regulates chloroacetaldehyde pharmacokinetics behaviour and alleviates high-dose cyclophosphamide-induced nephrotoxicity and neurotoxicity in rats.
    Basic & clinical pharmacology & toxicology, 2019, Volume: 125, Issue:2

    Topics: Acetaldehyde; Animals; Brain; Cyclophosphamide; Disease Models, Animal; Dose-Response Relationship,

2019